donepezil has been researched along with Pneumonia in 5 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients prescribed rivastigmine were more likely to report pneumonia as an adverse event than many drugs except galantamine." | 8.02 | The Association Between Use of Rivastigmine and Pneumonia: Systematic Analysis of FDA Adverse Event Reporting System. ( Bu, K; Cheng, F; Morris, R; Umeukeje, G, 2021) |
| "Donepezil seems to decrease in-hospital mortality as a result of pneumonia among older patients with dementia." | 7.88 | Donepezil is associated with decreased in-hospital mortality as a result of pneumonia among older patients with dementia: A retrospective cohort study. ( Abe, Y; Fushimi, K; Shimokado, K, 2018) |
| "Patients prescribed rivastigmine were more likely to report pneumonia as an adverse event than many drugs except galantamine." | 4.02 | The Association Between Use of Rivastigmine and Pneumonia: Systematic Analysis of FDA Adverse Event Reporting System. ( Bu, K; Cheng, F; Morris, R; Umeukeje, G, 2021) |
| "Donepezil seems to decrease in-hospital mortality as a result of pneumonia among older patients with dementia." | 3.88 | Donepezil is associated with decreased in-hospital mortality as a result of pneumonia among older patients with dementia: A retrospective cohort study. ( Abe, Y; Fushimi, K; Shimokado, K, 2018) |
| "The risk of pneumonia was higher in persons using rivastigmine patch (n = 9709) (adjusted hazard ratio (HR) 1." | 3.85 | Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease. ( Hartikainen, S; Lampela, P; Lavikainen, P; Taipale, H; Tanskanen, A; Tiihonen, J; Tolppanen, AM, 2017) |
| "To compare the risk of pneumonia in older adults receiving donepezil, galantamine, or rivastigmine for dementia." | 3.81 | Risk of pneumonia in new users of cholinesterase inhibitors for dementia. ( Hsieh, CY; Iwata, I; Kao Yang, YH; Lai, EC; Setoguchi, S; Wong, MB; Zhang, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morris, R | 1 |
| Umeukeje, G | 1 |
| Bu, K | 1 |
| Cheng, F | 1 |
| Abe, Y | 1 |
| Shimokado, K | 1 |
| Fushimi, K | 1 |
| Lai, EC | 1 |
| Wong, MB | 1 |
| Iwata, I | 1 |
| Zhang, Y | 1 |
| Hsieh, CY | 1 |
| Kao Yang, YH | 1 |
| Setoguchi, S | 1 |
| Lampela, P | 1 |
| Tolppanen, AM | 1 |
| Tanskanen, A | 1 |
| Tiihonen, J | 1 |
| Lavikainen, P | 1 |
| Hartikainen, S | 1 |
| Taipale, H | 1 |
| Seitz, DP | 1 |
| Gill, SS | 1 |
| Gruneir, A | 1 |
| Austin, PC | 1 |
| Anderson, G | 1 |
| Reimer, CL | 1 |
| Rochon, PA | 1 |
5 other studies available for donepezil and Pneumonia
| Article | Year |
|---|---|
The Association Between Use of Rivastigmine and Pneumonia: Systematic Analysis of FDA Adverse Event Reporting System.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Databas | 2021 |
Donepezil is associated with decreased in-hospital mortality as a result of pneumonia among older patients with dementia: A retrospective cohort study.
Topics: Aged; Dementia; Donepezil; Hospital Mortality; Humans; Pneumonia; Retrospective Studies | 2018 |
Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cohort Studies; Dementia; Donepezil; Female; Gal | 2015 |
Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Finland; Galanta | 2017 |
Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Cholinesterase Inhibitors; Cohort Studies; Critical Ca | 2011 |